EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
EGFR is frequently constitutively active in glioblastoma (GBM). Here, the authors show that EGFR induces YTHDF2 protein stabilization, which reduces cholesterol homeostasis through an RNA m6A methylation dependent molecular mechanism to promote GBM tumourigenesis.
Enregistré dans:
Auteurs principaux: | Runping Fang, Xin Chen, Sicong Zhang, Hui Shi, Youqiong Ye, Hailing Shi, Zhongyu Zou, Peng Li, Qing Guo, Li Ma, Chuan He, Suyun Huang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dbb72d0750a2491f8e7c06b1a87b4c5f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway.
par: Yaqiong Yang, et autres
Publié: (2021) -
Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR
par: Stefanie Moritz, et autres
Publié: (2021) -
Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
par: Leland S. Hu, et autres
Publié: (2021) -
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
par: Yulin Shi, et autres
Publié: (2019) -
Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina
par: Fahad Farhan, et autres
Publié: (2021)